Pharma giants pressed by Senate Democrats over Trump pricing deals
Source: SeekingAlpha
2026-03-06 10:45:02 ET
More on Pfizer, Merck, etc.
- Pfizer: Obesity Hype And Vaccine Policy Shocks
- AbbVie: Stabilizes Near $233 While Testing Resistance
- Pfizer's Portfolio Renewal In Progress - High Yields For The Patient
- China approves Pfizer’s GLP-1 drug for weight management, intensifying market competition
- J&J wins FDA nod for multiple myeloma therapy
Read the full article on Seeking Alpha
For further details see:
Pharma giants pressed by Senate Democrats over Trump pricing deals
Merck & Company Inc.
NASDAQ: MRK
MRK Trading
-0.5% G/L:
$114.88 Last:
3,277,543 Volume:
$115.155 Open:
MRK Latest News
March 05, 2026 10:20:00 am
Forget ImmunityBio: This Big?Cap Pharma Is the Safer Play on Next?Gen Cancer Therapies
March 03, 2026 09:00:00 am
Immunotherapy Delivers Across Tumor Types as Oncology Market Eyes $750 Billion
MRK Stock Data
$291,612,827,755
2,457,202,311
0.02%
2165
N/A
Pharmaceuticals
Healthcare
US
Rahway
